Attached files
file | filename |
---|---|
EX-32.2 - EXHIBIT 32.2 - KERYX BIOPHARMACEUTICALS INC | kerx-12312017x10kex322.htm |
EX-32.1 - EXHIBIT 32.1 - KERYX BIOPHARMACEUTICALS INC | kerx-12312017x10kex321.htm |
EX-31.2 - EXHIBIT 31.2 - KERYX BIOPHARMACEUTICALS INC | kerx-12312017x10kex312.htm |
EX-31.1 - EXHIBIT 31.1 - KERYX BIOPHARMACEUTICALS INC | kerx-12312017x10kex311.htm |
EX-23.1 - EXHIBIT 23.1 - KERYX BIOPHARMACEUTICALS INC | kerx-12312017x10kex231.htm |
EX-10.14 - EXHIBIT 10.14 - KERYX BIOPHARMACEUTICALS INC | kerx-12312017x10kex1014.htm |
EX-10.13 - EXHIBIT 10.13 - KERYX BIOPHARMACEUTICALS INC | kerx12312017-10kex1013.htm |
EX-10.12 - EXHIBIT 10.12 - KERYX BIOPHARMACEUTICALS INC | kerx12312017-10kex1012.htm |
10-K - 10-K - KERYX BIOPHARMACEUTICALS INC | kerx-12312017x10k.htm |
Exhibit 21.1
Keryx Biopharmaceuticals, Inc.
List of Subsidiaries
Name of Subsidiary | State/Jurisdiction of Incorporation |
ACCESS Oncology, Inc. | Delaware |
Accumin Diagnostics, Inc. | Delaware |
AOI Pharma, Inc. | Delaware |
AOI Pharmaceuticals, Inc. | Delaware |
Neryx Biopharmaceuticals, Inc. | Delaware |
Online Collaborative Oncology Group, Inc. | Delaware |
Keryx Biomedical Technologies Ltd. | Israel |
Keryx (Israel) Ltd. | Israel |
Keryx Biopharma UK Ltd. | United Kingdom |